Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry.
Colombo A, Chandrasekhar J, Aquino M, Ong TK, Sartori S, Baber U, Lee M, Iniguez A, Hajek P, Borisov B, Atzev B, Den Heijer P, Coufal Z, Hudec M, Mates M, Snyder C, Moalem K, Morrell D, Elmore F, Rowland S, Mehran R; MASCOT Investigators. Colombo A, et al. Among authors: iniguez a. Int J Cardiol. 2019 May 15;283:67-72. doi: 10.1016/j.ijcard.2019.01.053. Epub 2019 Jan 21. Int J Cardiol. 2019. PMID: 30826192
Differences in the use of guideline-recommended therapies among 14 European countries in patients with acute coronary syndromes undergoing PCI.
Zeymer U, James S, Berkenboom G, Mohacsi A, Iñiguez A, Coufal Z, Sartral M, Paget MA, Norrbacka K, Ferrieres J, Bakhai A; APTOR investigators. Zeymer U, et al. Among authors: iniguez a. Eur J Prev Cardiol. 2013 Apr;20(2):218-28. doi: 10.1177/2047487312437060. Epub 2012 Jan 24. Eur J Prev Cardiol. 2013. PMID: 22345684
Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial.
Jiménez-Quevedo P, Hernando L, Gómez-Hospital JA, Iñiguez A, SanRoman A, Alfonso F, Hernández-Antolín R, Angiolillo DJ, Bañuelos C, Escaned J, Gonzalo N, Fernández C, Macaya C, Sabaté M; DIABETES Investigators. Jiménez-Quevedo P, et al. Among authors: iniguez a. EuroIntervention. 2013 Jul;9(3):328-35. doi: 10.4244/EIJV9I3A54. EuroIntervention. 2013. PMID: 23518240 Free article. Clinical Trial.
Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trial.
Brugaletta S, Sabate M, Martin-Yuste V, Masotti M, Shiratori Y, Alvarez-Contreras L, Cequier A, Iñiguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Gomez-Lara J, Backx B, Serruys PW. Brugaletta S, et al. Among authors: iniguez a. Int J Cardiol. 2013 Oct 3;168(3):2632-6. doi: 10.1016/j.ijcard.2013.03.036. Epub 2013 Apr 8. Int J Cardiol. 2013. PMID: 23578890 Clinical Trial.
The Ibero-American transcatheter aortic valve implantation registry with the CoreValve prosthesis. Early and long-term results.
Muñoz-García AJ, del Valle R, Trillo-Nouche R, Elízaga J, Gimeno F, Hernández-Antolín R, Teles R, de Gama Ribeiro V, Molina E, Cequier A, Urbano-Carrillo C, Cruz-González I, Payaslian M, Patricio L, Sztejfman M, Iñiguez A, Rodríguez V, Scuteri A, Caorsi C, López-Otero D, Avanzas P, Alonso-Briales JH, Hernández-García JM, Morís C; Ibero-American registry investigators. Muñoz-García AJ, et al. Among authors: iniguez a. Int J Cardiol. 2013 Nov 20;169(5):359-65. doi: 10.1016/j.ijcard.2013.09.006. Epub 2013 Oct 4. Int J Cardiol. 2013. PMID: 24128731
Everolimus-eluting stent versus bare-metal stent in elderly (≥75 years) versus non-elderly (<75 years) patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the examination trial.
Ielasi A, Brugaletta S, Silvestro A, Cequier A, Iñiguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, den Heijer P, Bethencourt A, Vazquez N, Serruys P, Sabate M, Tespili M. Ielasi A, et al. Among authors: iniguez a. Int J Cardiol. 2015 Jan 20;179:73-8. doi: 10.1016/j.ijcard.2014.10.038. Epub 2014 Oct 22. Int J Cardiol. 2015. PMID: 25464418 Clinical Trial.
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial.
Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, García del Blanco B, García-Touchard A, López-Minguéz JR, Benedicto A, Masotti M, Zueco J, Iñiguez A, Velázquez M, Moreno R, Mainar V, Domínguez A, Pomar F, Melgares R, Rivero F, Jiménez-Quevedo P, Gonzalo N, Fernández C, Macaya C; RIBS IV Study Investigators (under auspices of Interventional Cardiology Working Group of Spanish Society of Cardiology). Alfonso F, et al. Among authors: iniguez a. J Am Coll Cardiol. 2015 Jul 7;66(1):23-33. doi: 10.1016/j.jacc.2015.04.063. J Am Coll Cardiol. 2015. PMID: 26139054 Free article. Clinical Trial.
Treatment of Small Vessel Disease With the Paclitaxel Drug-Eluting Balloon: 6-Month Angiographic and 1-Year Clinical Outcomes of the Spanish Multicenter Registry.
Vaquerizo B, Miranda-Guardiola F, Fernández E, Rumoroso JR, Gómez-Hospital JA, Bossa F, Iñiguez A, Oategui I, Serra A. Vaquerizo B, et al. Among authors: iniguez a. J Interv Cardiol. 2015 Oct;28(5):430-8. doi: 10.1111/joic.12227. Epub 2015 Sep 18. J Interv Cardiol. 2015. PMID: 26381619 Free article. Clinical Trial.
Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial.
Sabaté M, Brugaletta S, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, van Es GA, Backx B, Valgimigli M, Serruys PW. Sabaté M, et al. Among authors: iniguez a. Lancet. 2016 Jan 23;387(10016):357-366. doi: 10.1016/S0140-6736(15)00548-6. Epub 2015 Oct 29. Lancet. 2016. PMID: 26520230 Free article. Clinical Trial.
Comparison of the Efficacy of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With In-Stent Restenosis (from the RIBS IV and V Randomized Clinical Trials).
Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, García-Touchard A, Masotti M, López-Minguez JR, Iñiguez A, Zueco J, Velazquez M, Cequier A, Lázaro-García R, Martí V, Moris C, Urbano-Carrillo C, Bastante T, Rivero F, Cárdenas A, Gonzalo N, Jiménez-Quevedo P, Fernández C; Restenosis Intra-Stent: Drug-Eluting Balloon vs Everolimus-Eluting Stent (RIBS-IV and V Studies) Investigators (Under the auspices of the Interventional Cardiology Working Group of the Spanish Society of Cardiology). Alfonso F, et al. Among authors: iniguez a. Am J Cardiol. 2016 Feb 15;117(4):546-554. doi: 10.1016/j.amjcard.2015.11.042. Epub 2015 Dec 8. Am J Cardiol. 2016. PMID: 26725102 Clinical Trial.
335 results